PLEASE NOTE ALL AGENDA TIMES, SPEAKERS AND TOPICS ARE SUBJECT TO CHANGE UNTIL FINAL AGENDA IS CONFIRMED

Conference Agenda

 

  Go
  • Friday, July 10, 2020
  •  

    Registration

    7:00 AM  -  8:00 AM
    Primary Care Conference Registration
     

    Primary Care Conference

    8:00 AM  -  9:00 AM
    Keynote: Leading with Urgency
    9:15 AM  -  10:15 AM
    PCEC1: IBS: Easing the Patient Burden
    Family care clinicians are the first line of defense for patients suffering from IBS, a common disorder that causes substantial reduction in health-related quality of life. The diagnosis of IBS, whether it is IBS-D, IBS-M, or IBS-C, is generally made clinically, which is impacted by recent changes in the Rome criteria. Now recognized as both a brain-gut and a gut-brain disorder, the treatment of patients with IBS has evolved significantly in the past year. Understanding the patient burden of disease, particularly symptoms that are most troublesome, is helpful in individualizing therapy. The 2018 American College of Gastroenterology IBS guidelines lend clarity to treatments found effective, including soluble fiber and several medications, while finding little evidence to support the use of therapies such as a gluten-free diet, prebiotics/probiotics/synbiotics, and antispasmodics. Presentation presented by the Primary Care Education Consortium (PCEC). You will receive a certificate of participation for this activity. ANCC accepts AAFP Prescribed credit. and AMA PRA Category 1 Credits. Grant funded by Salix Pharmaceuticals, Inc.
    10:25 AM  -  11:25 AM
    A1: Depression in LGBTQ Community
    11:25 AM  -  12:00 PM
    Sign in with Sponsor for Product Theater
    12:00 PM  -  1:00 PM
    LP1: NON-CE Product Theater Lunch Session
    This session is provided by a commercial interest. Contact Hours will not be awarded.
    1:15 PM  -  2:15 PM
    PCEC2: Diabetes Management: Putting the Patient First
    The management of patients with T2DM has undergone a seismic shift from a glucose- centric to a patient-centric focus with a primary goal of reducing cardiovascular risk. The shift to focus on cardiovascular risk stems not only from the fact that microvascular and macrovascular complications continue to be common in persons with type 2 diabetes mellitus, but also from evolving evidence clearly demonstrating cardiovascular risk reduction with some antidiabetic medications. To reduce the burden of disease and improve the journey of persons with type 2 diabetes, however, requires understanding the evidence base for these benefits and differences among the antidiabetic medications, and how treatment can be individualized to address the unmet needs of each patient. Presentation presented by the Primary Care Education Consortium (PCEC). You will receive a certificate of participation for this activity. ANCC accepts AAFP Prescribed credit. and AMA PRA Category 1 Credits. Grant funded by Lilly.
    2:25 PM  -  3:25 PM
    B1: Common Orthopedic Conditions in Primary Care
     
    4:30 PM  -  7:30 PM
    Psoriasis Dinner Program

    In conjunction with the National Psoriasis Foundation this Psoriasis Recognition Program is designed to help enhance your skills in caring for those with psoriasis. After completing this program, attendees will be formally recognized as up-to-date in the latest psoriasis education.

    This activity is supported by educational grants from Bristol-Myers Squibb and Janssen.

    The National Psoriasis Foundation designates this live activity for a maximum of 3.0 AMA PRA Category 1 CreditsTM

  • Saturday, July 11, 2020
  •  

    Primary Care Conference

    7:00 AM  -  8:00 AM
    BR1: Influenza Treatment in the Primary Care Setting

    By completing this session, participants will be able to apply new evidence into practice regarding the use of diagnostic testing, treatment and chemoprophylaxis for people with, or at risk for, influenza. Also, Incorporate the use of antiviral agents into practice based on their ability to reduce transmission, as well as treat people with influenza who are at normal or high risk for complications.

    Content Developed by: John J. Russell, MD, Clinical Professor of Family and Community Medicine, Thomas Jefferson University Sidney Kimmel School of Medicine, Philadelphia, PA; Chair, Department of Family Medicine and Program Director, Family Medicine Residency, Abington – Jefferson Health, Abington, PA

    This activity is supported by an educational grant from Genentech, Inc.
    This continuing nurse education activity is provided by Vindico Medical Education.

    8:15 AM  -  9:15 AM
    C1: Dizziness and Vertigo: Assessment and Treatment
    9:15 AM  -  9:45 AM
    Exhibit Hall Grand Opening
    9:45 AM  -  10:45 AM
    D1: Orthopedic Examination and Diagnostic Imaging
    10:55 AM  -  11:55 AM
    E1:
    11:55 AM  -  12:30 PM
    Sign in with Sponsor for Product Theater
    12:30 PM  -  1:30 PM
    LP2: NON-CE Product Theater Lunch Session

    Renal and Cardiovascular Outcomes in Patients with Diabetic Nephropathy (ie, Diabetic Kidney Disease) and Type 2 Diabetes

    This session is provided by a commercial interest. Contact Hours will not be awarded.

    1:45 PM  -  2:45 PM
    F1: Important Cardiology Considerations when Performing Sports Physicals
    3:15 PM  -  4:15 PM
    G1:
  • Sunday, July 12, 2020
  •  

    Registration

    7:00 AM  -  8:00 AM
    Pharmacology Conference Registration
     

    Pharmacology Conference

    8:00 AM  -  9:30 AM
    PH1: Pharmacologic Management of Depression in Primary Care
    10:00 AM  -  11:30 AM
    PH2: Diagnosis and Management of ADHD for the Primary Care Provider
    11:30 AM  -  12:00 PM
    Sign in with Sponsor for Product Theater
    12:00 PM  -  1:00 PM
    PH-LP1: NON-CE Product Theater Lunch Session
    This session is provided by a commercial interest. Contact Hours will not be awarded.
    1:15 PM  -  2:45 PM
    PH3: COPD Pharmacology Update
    Speakers:
    3:00 PM  -  4:30 PM
    PH4: Vaping Update and Smoking Cessation Pharmacology
    Speakers:
  • Monday, July 13, 2020
  •  

    Pharmacology Conference

    7:00 AM  -  8:00 AM
    PH-BR1: Expanding the Role of the NP in Managing Major Depressive Disorder: Challenge Accepted

    Supporter Statement: This activity is supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc. and Lundbeck.

    Provider Statement: This continuing nurse education activity is provided by Vindico Medical Education.

    8:15 AM  -  9:45 AM
    PH5: Challenges in Osteoporosis and Fracture Prevention
    10:00 AM  -  11:30 AM
    PH6: Update on the Management of Peri-Menopausal and Menopausal Women
    11:30 AM  -  12:00 PM
    Sign in with Sponsor for Product Theater
    12:00 PM  -  1:00 PM
    PH-LP2: NON-CE Product Theater Lunch Session
    This session is provided by a commercial interest. Contact Hours will not be awarded.
    1:15 PM  -  2:45 PM
    PH7: Migraine: What's Old, What's New
    3:00 PM  -  4:30 PM
    PH8: Non-Opioid Pharmacology for Treating Pain
Top